Ghost Tree Capital’s Sierra Oncology SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-325,000
Closed -$10.4M – 50
2022
Q1
$10.4M Buy
325,000
+75,000
+30% +$2.15M 2.26% 8
2021
Q4
$5.44M Buy
250,000
+50,000
+25% +$1.1M 1.95% 18
2021
Q3
$4.38M Hold
200,000
– – 1.28% 29
2021
Q2
$3.89M Hold
200,000
– – 1.07% 34
2021
Q1
$3.45M Hold
200,000
– – 0.81% 38
2020
Q4
$3.21M Buy
+200,000
New +$2.78M 0.71% 35

Other funds holding SRRA

Ghost Tree Capital's SRRA Position: Q2 2022 in Review

Ghost Tree Capital sold out of Sierra Oncology (SRRA) in Q2 2022, closing a stake of 325,000 shares — an estimated $10.4M sold.

Ghost Tree Capital first reported a position in SRRA in Q4 2020 and held it in 6 quarters. The position peaked at $10.4M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

  • Ghost Tree Capital reported no remaining Sierra Oncology position as of Q2 2022 after selling out during the quarter.
  • Ghost Tree Capital sold 325,000 Sierra Oncology shares in Q2 2022, an estimated $10.4M.
  • Ghost Tree Capital first reported a position in Sierra Oncology in Q4 2020 and held it in 6 quarters.
  • Ghost Tree Capital's Sierra Oncology position peaked at $10.4M in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Sierra Oncology as of Q2 2022.

Based on Ghost Tree Capital's 13F filing for Q2 2022, filed 15 Aug 2022.